This results in an enhanced TGF-β production to promote tumor infiltration and the immunosuppression function of Tregs by upregulating the expression of inhibitory molecules, such as B7H1 and glucocorticoid-induced tumor necrosis factor receptor-related ligand (GITRL), on the surface of APCs [551]. The gene discussed is CD274; the disease is neoplasm.